Barry M, Molloy D, Usher C, Tilson L
National Centre for Pharmacoeconomics, St James's Hospital, Dublin.
Ir Med J. 2008 Nov-Dec;101(10):299-302.
Community prescribing accounts for approximately 85% of total drug expenditure. In 2007 spending on medicines under the Community Drugs Schemes exceeded Euro 1.74 billion, a five-fold increase over the decade 1997-2007. The year on year increase in spending on medicines is amongst the highest in Europe. The desire of the HSE to reduce or at least contain drug expenditure is appreciated and is consistent with approaches across other EU member states. Recent developments in drug pricing and reimbursement as outlined here may help to contain the drugs bill. However, the emergence of promising but expensive biologic agents for cancer therapy and other chronic conditions threaten any cost containment measures.
社区配药约占药品总支出的85%。2007年，社区药物计划下的药品支出超过17.4亿欧元，是1997年至2007年这十年间的五倍。药品支出的年增长率在欧洲名列前茅。卫生服务执行局（HSE）希望减少或至少控制药品支出，这一点值得赞赏，并且与其他欧盟成员国的做法一致。此处概述的药品定价和报销方面的最新进展可能有助于控制药品费用。然而，用于癌症治疗和其他慢性病的前景广阔但价格昂贵的生物制剂的出现，对任何成本控制措施都构成了威胁。
